TD Asset Management Inc. lowered its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 5.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 201,556 shares of the company’s stock after selling 11,255 shares during the quarter. TD Asset Management Inc. owned 0.23% of Acadia Healthcare worth $9,626,000 at the end of the most recent quarter.
Several other hedge funds have also recently made changes to their positions in ACHC. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Acadia Healthcare by 11.1% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,704 shares of the company’s stock valued at $134,000 after buying an additional 270 shares in the last quarter. C M Bidwell & Associates Ltd. purchased a new position in shares of Acadia Healthcare in the second quarter valued at $205,000. Riverhead Capital Management LLC purchased a new stake in Acadia Healthcare during the 2nd quarter worth about $209,000. Rathbone Brothers plc purchased a new stake in Acadia Healthcare during the 3rd quarter worth about $223,000. Finally, World Asset Management Inc purchased a new stake in Acadia Healthcare during the 2nd quarter worth about $242,000.
Shares of Acadia Healthcare Company, Inc. (NASDAQ ACHC) opened at $32.26 on Friday. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 1.30. The company has a market capitalization of $2,834.17, a PE ratio of 14.09, a price-to-earnings-growth ratio of 1.20 and a beta of 0.90. Acadia Healthcare Company, Inc. has a fifty-two week low of $26.92 and a fifty-two week high of $54.34.
A number of research firms recently commented on ACHC. Jefferies Group set a $42.00 price objective on Acadia Healthcare and gave the stock a “buy” rating in a research report on Wednesday, October 25th. BMO Capital Markets began coverage on Acadia Healthcare in a research report on Monday, October 16th. They set an “outperform” rating and a $52.00 price objective for the company. Craig Hallum reiterated a “buy” rating and set a $41.00 price objective (down previously from $65.00) on shares of Acadia Healthcare in a research report on Thursday, October 26th. Zacks Investment Research cut Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, October 2nd. Finally, Bank of America dropped their price objective on Acadia Healthcare from $60.00 to $52.00 and set a “buy” rating for the company in a research report on Wednesday, October 25th. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and nine have issued a buy rating to the stock. Acadia Healthcare currently has a consensus rating of “Hold” and a consensus price target of $45.15.
WARNING: This report was reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this report on another domain, it was illegally copied and reposted in violation of US & international trademark & copyright legislation. The legal version of this report can be accessed at https://www.com-unik.info/2017/12/03/acadia-healthcare-company-inc-achc-shares-sold-by-td-asset-management-inc.html.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC).
What are top analysts saying about Acadia Healthcare Company Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Acadia Healthcare Company Inc. and related companies.